Akanda Corp. received a Deficiency Letter from Nasdaq on June 16, 2026, for failing to maintain the required $2.5 million in stockholders’ equity under Listing Rule 5550(b)(1). The company submitted a compliance plan on July 31, 2026, which was supplemented on August 12, 2026. Nasdaq granted an extension through December 13, 2026, allowing the company to regain compliance or request further discretion-based extensions. Failure to meet these requirements may result in delisting from Nasdaq. Akanda Corp. operates in the cannabis industry.
